[HTML][HTML] FTO promotes multiple myeloma progression by posttranscriptional activation of HSF1 in an m6A-YTHDF2-dependent manner

A Xu, J Zhang, L Zuo, H Yan, L Chen, F Zhao, F Fan… - Molecular Therapy, 2022 - cell.com
N 6-methyladenosine (m 6 A), as the most pervasive internal modification of eukaryotic
mRNA, plays a crucial role in various cancers, but its role in multiple myeloma (MM) …

FTO promotes multiple myeloma progression by posttranscriptional activation of HSF1 in an m6A-YTHDF2-dependent manner

A Xu, J Zhang, L Zuo, H Yan, L Chen… - … therapy: the journal …, 2022 - pubmed.ncbi.nlm.nih.gov
N 6-methyladenosine (m 6 A), as the most pervasive internal modification of eukaryotic
mRNA, plays a crucial role in various cancers, but its role in multiple myeloma (MM) …

[HTML][HTML] FTO promotes multiple myeloma progression by posttranscriptional activation of HSF1 in an m6A-YTHDF2-dependent manner

A Xu, J Zhang, L Zuo, H Yan, L Chen, F Zhao… - Molecular …, 2022 - ncbi.nlm.nih.gov
Abstract N 6-methyladenosine (m 6 A), as the most pervasive internal modification of
eukaryotic mRNA, plays a crucial role in various cancers, but its role in multiple myeloma …

[HTML][HTML] FTO promotes multiple myeloma progression by posttranscriptional activation of HSF1 in an m6A-YTHDF2-dependent manner

A Xu, J Zhang, L Zuo, H Yan, L Chen, F Zhao, F Fan… - Molecular Therapy, 2022 - Elsevier
N 6-methyladenosine (m 6 A), as the most pervasive internal modification of eukaryotic
mRNA, plays a crucial role in various cancers, but its role in multiple myeloma (MM) …

FTO promotes multiple myeloma progression by posttranscriptional activation of HSF1 in an m6A-YTHDF2-dependent manner.

A Xu, J Zhang, L Zuo, H Yan, L Chen… - … Therapy: the Journal …, 2021 - europepmc.org
Abstract N 6-methyladenosine (m 6 A), as the most pervasive internal modification of
eukaryotic mRNA, plays a crucial role in various cancers, but its role in multiple myeloma …